001     304849
005     20251211150901.0
024 7 _ |a 10.1136/jech-2025-224476
|2 doi
024 7 _ |a pmid:40987569
|2 pmid
024 7 _ |a 0143-005X
|2 ISSN
024 7 _ |a 0141-7681
|2 ISSN
024 7 _ |a 0142-467X
|2 ISSN
024 7 _ |a 1470-2738
|2 ISSN
024 7 _ |a 2633-9196
|2 ISSN
037 _ _ |a DKFZ-2025-01955
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Manfredi, Luca
|0 0000-0002-6530-4326
|b 0
245 _ _ |a Does lifestyle explain the relationship between socioeconomic position and multimorbidity of cancer and cardiometabolic diseases? A mediation analysis applied to the European Prospective Investigation into Cancer and Nutrition.
260 _ _ |a London
|c 2025
|b BMJ Publ. Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1765462104_155781
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2025 Dec 10;80(1):3-9
520 _ _ |a Multimorbidity is socially patterned, with lower socioeconomic position (SEP) linked to higher risk. We examined whether a Healthy Lifestyle Index (HLI) mediates the SEP-multimorbidity association and whether pathways differ by sex.We used data from 244 886 participants in the European Prospective Investigation into Cancer and Nutrition study. HLI was derived from smoking, alcohol consumption, physical activity, body mass index and diet. SEP was categorised into low, medium and high-SEP based on education. Multimorbidity was defined as the coexistence of at least two diseases among cancer, type 2 diabetes and cardiovascular diseases. Logistic regression assessed SEP-HLI association, Cox regression SEP-multimorbidity and HLI-multimorbidity associations. Counterfactual mediation analysis estimated the natural indirect effect (NIE) and pure direct effect (PDE). Analyses were stratified by sex.Participants from lower SEP categories were older with worse health outcomes. Women had a healthier lifestyle than men across all SEP levels. In men, the hazard ratio of developing multimorbidity was 1.40 (95% CI: 1.26 to 1.54) for those with low SEP compared with high SEP, in women 1.74 (95% CI: 1.52 to 2.00). Comparing low versus high SEP, PDE for men was 1.28 (95% CI: 1.15 to 1.41), NIE was 1.09 (95% CI: 1.07 to 1.11) (proportion mediated (PM)=29%). In women, PDE was 1.65 (95% CI: 1.47 to 1.90), NIE 1.05 (95% CI: 1.03 to 1.06) (PM=11%).Lifestyle behaviours partly mediated the SEP-multimorbidity association, underscoring the need to integrate considerations of socioeconomic disparities into the planning of lifestyle interventions.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a EPIDEMIOLOGY
|2 Other
650 _ 7 |a Health inequalities
|2 Other
650 _ 7 |a Healthy Aging
|2 Other
650 _ 7 |a LIFE STYLE
|2 Other
650 _ 7 |a PUBLIC HEALTH
|2 Other
700 1 _ |a Buscema, Federica
|b 1
700 1 _ |a Giraudo, Maria Teresa
|b 2
700 1 _ |a Sodano, Barbara
|b 3
700 1 _ |a Padroni, Lisa
|b 4
700 1 _ |a Destefanis, Cinzia
|b 5
700 1 _ |a Freisling, Heinz
|b 6
700 1 _ |a Ferrari, Pietro
|b 7
700 1 _ |a Cesaroni, Giulia
|b 8
700 1 _ |a Uzzau, Sergio
|b 9
700 1 _ |a Schulze, Matthias B
|b 10
700 1 _ |a Saieva, Calogero
|b 11
700 1 _ |a Tumino, Rosario
|b 12
700 1 _ |a Weiderpass, Elisabete
|b 13
700 1 _ |a Matta, Komodo
|b 14
700 1 _ |a Vaccarella, Salvatore
|b 15
700 1 _ |a Guevara, Marcela
|b 16
700 1 _ |a Halkjær, Jytte
|b 17
700 1 _ |a Tjønneland, Anne
|b 18
700 1 _ |a Crous-Bou, Marta
|b 19
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 20
|u dkfz
700 1 _ |a Pour, Toktam
|0 P:(DE-He78)2110f05d2116acc3cfc7024c226128ad
|b 21
|u dkfz
700 1 _ |a Panico, Salvatore
|b 22
700 1 _ |a Pala, Valeria
|b 23
700 1 _ |a Tzoulaki, Ioanna
|b 24
700 1 _ |a Tin Tin, Sandar
|b 25
700 1 _ |a Dahm, Christina C
|b 26
700 1 _ |a Chirlaque, MªDolores
|b 27
700 1 _ |a Sacerdote, Carlotta
|b 28
700 1 _ |a Ricceri, Fulvio
|0 0000-0001-8749-9737
|b 29
773 _ _ |a 10.1136/jech-2025-224476
|g p. jech-2025-224476 -
|0 PERI:(DE-600)2015405-7
|n 1
|p 3-9
|t Journal of epidemiology and community health
|v 80
|y 2025
|x 0143-005X
909 C O |p VDB
|o oai:inrepo02.dkfz.de:304849
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 20
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 21
|6 P:(DE-He78)2110f05d2116acc3cfc7024c226128ad
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2025
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2023-08-23
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-23
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1180
|2 StatID
|b Current Contents - Social and Behavioral Sciences
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0130
|2 StatID
|b Social Sciences Citation Index
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-08-23
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J EPIDEMIOL COMMUN H : 2022
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-08-23
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-08-23
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J EPIDEMIOL COMMUN H : 2022
|d 2023-08-23
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21